BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20010089)

  • 1. Hepatic metastases from neuroendocrine tumors with a "thin slice" pathological examination: they are many more than you think..
    Elias D; Lefevre JH; Duvillard P; Goéré D; Dromain C; Dumont F; Baudin E
    Ann Surg; 2010 Feb; 251(2):307-10. PubMed ID: 20010089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.
    Scigliano S; Lebtahi R; Maire F; Stievenart JL; Kianmanesh R; Sauvanet A; Vullierme MP; Couvelard A; Belghiti J; Ruszniewski P; Le Guludec D
    Endocr Relat Cancer; 2009 Sep; 16(3):977-90. PubMed ID: 19470616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver.
    Elias D; Goéré D; Leroux G; Dromain C; Leboulleux S; de Baere T; Ducreux M; Baudin E
    Eur J Surg Oncol; 2009 Oct; 35(10):1092-7. PubMed ID: 19464140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of hepatic metastases from colorectal carcinoma: comparison of histopathologic features of anatomically resected liver with results of preoperative imaging.
    Nomura K; Kadoya M; Ueda K; Fujinaga Y; Miwa S; Miyagawa S
    J Clin Gastroenterol; 2007 Sep; 41(8):789-95. PubMed ID: 17700429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases.
    Elias D; Santoro R; Ouellet JF; Osmak L; de Baere T; Roche A
    Hepatogastroenterology; 2004; 51(60):1788-91. PubMed ID: 15532827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging.
    Dromain C; de Baere T; Lumbroso J; Caillet H; Laplanche A; Boige V; Ducreux M; Duvillard P; Elias D; Schlumberger M; Sigal R; Baudin E
    J Clin Oncol; 2005 Jan; 23(1):70-8. PubMed ID: 15625361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.
    Rockall AG; Planche K; Power N; Nowosinska E; Monson JP; Grossman AB; Reznek RH
    Neuroendocrinology; 2009; 89(3):288-95. PubMed ID: 19023191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of unknown primary tumors in patients with neuroendocrine liver metastases.
    Wang SC; Parekh JR; Zuraek MB; Venook AP; Bergsland EK; Warren RS; Nakakura EK
    Arch Surg; 2010 Mar; 145(3):276-80. PubMed ID: 20231629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of unsuspected and treatable metastatic disease associated with operable colorectal liver metastases discovered only at laparotomy (and not treated when performing percutaneous radiofrequency ablation).
    Elias D; Sideris L; Pocard M; de Baere T; Dromain C; Lassau N; Lasser P
    Ann Surg Oncol; 2005 Apr; 12(4):298-302. PubMed ID: 15827682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease.
    Frilling A; Li J; Malamutmann E; Schmid KW; Bockisch A; Broelsch CE
    Br J Surg; 2009 Feb; 96(2):175-84. PubMed ID: 19160361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hepatic metastases of neuroendocrine malignancies: a 10-year experience.
    Dejong CH; Parks RW; Currie E; Piris J; Redhead DN; Garden OJ
    J R Coll Surg Edinb; 2002 Apr; 47(2):495-9. PubMed ID: 12018694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-step surgery for synchronous bilobar liver metastases from digestive endocrine tumors: a safe approach for radical resection.
    Kianmanesh R; Sauvanet A; Hentic O; Couvelard A; Lévy P; Vilgrain V; Ruszniewski P; Belghiti J
    Ann Surg; 2008 Apr; 247(4):659-65. PubMed ID: 18362629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms.
    Cho CS; Labow DM; Tang L; Klimstra DS; Loeffler AG; Leverson GE; Fong Y; Jarnagin WR; D'Angelica MI; Weber SM; Blumgart LH; Dematteo RP
    Cancer; 2008 Jul; 113(1):126-34. PubMed ID: 18457323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging follow-up of liver growth of neuroendocrine tumors in an experimental mouse model.
    Baboi L; Pilleul F; Milot L; Lartizien C; Poncet G; Roche C; Scoazec JY; Beuf O
    Magn Reson Imaging; 2010 Feb; 28(2):264-72. PubMed ID: 19695818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
    Atwell TD; Charboneau JW; Que FG; Rubin J; Lewis BD; Nagorney DM; Callstrom MR; Farrell MA; Pitot HC; Hobday TJ
    Cardiovasc Intervent Radiol; 2005; 28(4):409-21. PubMed ID: 16041556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study.
    Elias D; Lasser P; Ducreux M; Duvillard P; Ouellet JF; Dromain C; Schlumberger M; Pocard M; Boige V; Miquel C; Baudin E
    Surgery; 2003 Apr; 133(4):375-82. PubMed ID: 12717354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly aggressive policy of hepatic resections for neuroendocrine liver metastases.
    Grazi GL; Cescon M; Pierangeli F; Ercolani G; Gardini A; Cavallari A; Mazziotti A
    Hepatogastroenterology; 2000; 47(32):481-6. PubMed ID: 10791218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review.
    Yedibela S; Gohl J; Graz V; Pfaffenberger MK; Merkel S; Hohenberger W; Meyer T
    Ann Surg Oncol; 2005 Oct; 12(10):778-85. PubMed ID: 16132374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of contrast-enhanced computed tomography, computed tomography during arterioportography, and magnetic resonance imaging for staging colorectal liver metastases for liver resection.
    Bhattacharjya S; Bhattacharjya T; Baber S; Tibballs JM; Watkinson AF; Davidson BR
    Br J Surg; 2004 Oct; 91(10):1361-9. PubMed ID: 15376205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.